Novo Nordisk Says Execs Didn't Hide Insulin Sales Woes
Danish insulin maker Novo Nordisk A/S on Wednesday urged a New Jersey federal judge to dismiss a proposed class action accusing it of misleading investors about its financial sustainability amid U.S....To view the full article, register now.
Already a subscriber? Click here to view full article